PODD
Insulet Corporation
Medical Devices · Healthcare · United States
146.44
close · 2026-08-13
value
42
cheaper than peers42
quality
95
stronger fundamentals95
ranked against
Medical Devices
value
quality
55 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 18.99× | 59 |
| EV to EBITDA | 16.59× | 50 |
| price to sales | 3.24× | 47 |
| price to book | 7.14× | 29 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 26.0% | 95 |
| revenue growth | 23.5% | 86 |
| operating margin | 16.2% | 81 |
| debt to equity | 66.7% | 44 |
4 of 4 measures available
Facts
| market cap | $10B |
| free cash flow | $236.9M |
| employees | 5,400 |
| first trade | 2007-05-15 |
| next earnings | 2026-08-05 |
| fundamentals updated | 2026-08-10 |